{"compose":{"include":[{"system":"http://hl7.org/fhir/v2/0417"}]},"contact":[{"telecom":[{"system":"other","value":"http://hl7.org"}]}],"description":"FHIR Value set/code system definition for HL7 v2 table 0417 ( Tissue Type Code)","experimental":true,"id":"v2-0417","meta":{"profile":["http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition"]},"name":"v2 Tissue Type Code","publisher":"HL7, Inc","resourceType":"ValueSet","status":"active","text":{"div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Tissue Type Code</p>\r\n<table class=\"grid\"><tr><td><b>Code</b></td><td><b>Description</b></td><td><b>Comment</b></td><td><b>Version</b></td></tr><tr><td>0<a name=\"0\"> </a></td><td>No tissue expected</td><td/><td>added v2.4</td></tr><tr><td>1<a name=\"1\"> </a></td><td>Insufficient Tissue</td><td/><td>added v2.4</td></tr><tr><td>2<a name=\"2\"> </a></td><td>Not abnormal</td><td/><td>added v2.4</td></tr><tr><td>3<a name=\"3\"> </a></td><td>Abnormal-not categorized</td><td/><td>added v2.4</td></tr><tr><td>4<a name=\"4\"> </a></td><td>Mechanical abnormal</td><td/><td>added v2.4</td></tr><tr><td>5<a name=\"5\"> </a></td><td>Growth alteration</td><td/><td>added v2.4</td></tr><tr><td>6<a name=\"6\"> </a></td><td>Degeneration &amp; necrosis</td><td/><td>added v2.4</td></tr><tr><td>7<a name=\"7\"> </a></td><td>Non-acute inflammation</td><td/><td>added v2.4</td></tr><tr><td>8<a name=\"8\"> </a></td><td>Non-malignant neoplasm</td><td/><td>added v2.4</td></tr><tr><td>9<a name=\"9\"> </a></td><td>Malignant neoplasm</td><td/><td>added v2.4</td></tr><tr><td>B<a name=\"B\"> </a></td><td>Basal cell carcinoma</td><td/><td>added v2.4</td></tr><tr><td>C<a name=\"C\"> </a></td><td>Carcinoma-unspecified type</td><td/><td>added v2.4</td></tr><tr><td>G<a name=\"G\"> </a></td><td>Additional tissue required</td><td/><td>added v2.4</td></tr></table>\r\n</div>","status":"additional"},"url":"http://hl7.org/fhir/ValueSet/v2-0417","version":"2.8.2"}